The issue of bisphosphonate holidays has again been raised by US researchers who found that therapy beyond five years was not associated with lower risk of hip fracture in postmenopausal women. In an observational study involving 29,685 women who took bisphosphonates for five years, there was no difference in hip fracture risk among those who ...
No bisphosphonate benefit beyond five years: study
By Michael Woodhead
9 Dec 2020